The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of single-cell cytokine secretion with clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with capecitabine (C), bevacizumab (B), ± atezolizumab (A).
 
Niharika B. Mettu
Research Funding - Amgen (Inst); Amphivena (Inst); Aravive (Inst); AstraZeneca/MedImmune (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); ERYTECH Pharma (Inst); Genentech (Inst); Incyte (Inst); Merck (Inst); Mereo BioPharma (Inst); Repare Therapeutics (Inst); Syros Pharmaceuticals (Inst)
 
Blake Waechter
No Relationships to Disclose
 
Tyler J. Zemla
No Relationships to Disclose
 
Yingmiao Liu
No Relationships to Disclose
 
John C. Brady
No Relationships to Disclose
 
Lynn Lin
No Relationships to Disclose
 
Sacha Gnjatic
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); EMD Serono (Inst); Genentech (Inst); Janssen (Inst); Regeneron (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Patent on GM-CSF autoantibodies; Patent on Multiplex Immunohistochemistry with Chromogen Staining on a Single Slide (MICSSS); Patents related to immune composition of NY-ESO-1 and peptides.; Provisional patent on ELLA cytokines
 
Kent J. Weinhold
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca; Bayer (Inst); BeiGene; Boehringer Ingelheim; Caladrius Biosciences; Caladrius Biosciences; Celularity; Daiichi Sankyo/UCB Japan; Deciphera; Eisai; Eisai; Exact Sciences; Foundation Medicine; Foundation Medicine; Illumina; Immuneering; Incyte (Inst); Ipsen (Inst); Janssen; Kanaph Therapeutics; Lilly (Inst); Natera; Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SOBI; Stemline Therapeutics; Treos Bio; Zai Lab
Patents, Royalties, Other Intellectual Property - Patent WO/2018/183488; Patent WO/2019/055687
Other Relationship - 1Globe Health Institute; AstraZeneca; Exelixis; FibroGen; Imugene; Lilly; Merck (Inst); Pancreatic Cancer Action Network; Replimune; Sun Biopharma; Suzhou Kintor Pharmaceuticals; UpToDate; Xilis
 
Fang-Shu Ou
No Relationships to Disclose
 
Andrew B. Nixon
Consulting or Advisory Role - AdjuVolt; Leap Therapeutics; Promega
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Genmab (Inst); HTG Molecular Diagnostics (Inst); medpacto (Inst); Promega (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)